Strengthening pharmacotherapy research for COVID-19-induced pulmonary fibrosis
Description
The global spread of severe acute respiratory syndrome coronavirus 2 has resulted in a significant number of individuals developing pulmonary fibrosis (PF), an irreversible lung injury. This condition can manifest within a short interval following